| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2
|
Vachon, Celine M.
|
|
2015
|
149 |
2 |
p. 517-523
|
artikel
|
| 2 |
A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies trastuzumab and lapatinib
|
Elster, N.
|
|
2014
|
149 |
2 |
p. 373-383
|
artikel
|
| 3 |
Autoimmune diseases and breast cancer recurrence: a Danish nationwide cohort study
|
Lietzen, Lone Winther
|
|
2015
|
149 |
2 |
p. 497-504
|
artikel
|
| 4 |
Biological and clinical significance of PARP1 protein expression in breast cancer
|
Green, Andrew R.
|
|
2014
|
149 |
2 |
p. 353-362
|
artikel
|
| 5 |
C-kit overexpression correlates with KIT gene copy numbers increases in phyllodes tumors of the breast
|
Liu, Junjun
|
|
2014
|
149 |
2 |
p. 395-401
|
artikel
|
| 6 |
Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis
|
Li, Yanchun
|
|
2014
|
149 |
2 |
p. 403-415
|
artikel
|
| 7 |
Effectiveness of an additional individualized multi-component complementary medicine treatment on health-related quality of life in breast cancer patients: a pragmatic randomized trial
|
Witt, Claudia M.
|
|
2015
|
149 |
2 |
p. 449-460
|
artikel
|
| 8 |
Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis
|
Pedro, María de
|
|
2015
|
149 |
2 |
p. 525-536
|
artikel
|
| 9 |
Erratum to: A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure
|
Massarweh, Suleiman
|
|
2015
|
149 |
2 |
p. 565
|
artikel
|
| 10 |
Erratum to: Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis
|
Drukker, C. A.
|
|
2015
|
149 |
2 |
p. 567
|
artikel
|
| 11 |
History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response
|
Huzell, Louise
|
|
2015
|
149 |
2 |
p. 505-515
|
artikel
|
| 12 |
Impact of chemotherapy on telomere length in sporadic and familial breast cancer patients
|
Benitez-Buelga, C.
|
|
2014
|
149 |
2 |
p. 385-394
|
artikel
|
| 13 |
Increased pSmad2 expression and cytoplasmic predominant presence of TGF-βRII in breast cancer tissue are associated with poor prognosis: results from the Shanghai Breast Cancer Study
|
Qiu, Qingchao
|
|
2014
|
149 |
2 |
p. 467-477
|
artikel
|
| 14 |
Infection risk in breast cancer patients treated with trastuzumab: a systematic review and meta-analysis
|
Funakoshi, Tomohiro
|
|
2014
|
149 |
2 |
p. 321-330
|
artikel
|
| 15 |
INPP4B and RAD50 have an interactive effect on survival after breast cancer
|
Dai, Xiaofeng
|
|
2014
|
149 |
2 |
p. 363-371
|
artikel
|
| 16 |
Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin
|
Braunstein, Lior Z.
|
|
2015
|
149 |
2 |
p. 555-564
|
artikel
|
| 17 |
Long-term clinical outcomes in women with breast pain in the absence of additional clinical findings: mammography remains indicated
|
Noroozian, Mitra
|
|
2015
|
149 |
2 |
p. 417-424
|
artikel
|
| 18 |
Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy
|
Pfefferle, Adam D.
|
|
2015
|
149 |
2 |
p. 425-437
|
artikel
|
| 19 |
Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry
|
Nguyen-Dumont, Tú
|
|
2015
|
149 |
2 |
p. 547-554
|
artikel
|
| 20 |
Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer
|
Bertrand, Kimberly A.
|
|
2014
|
149 |
2 |
p. 479-487
|
artikel
|
| 21 |
Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial
|
Liu, Shuzhen
|
|
2015
|
149 |
2 |
p. 439-448
|
artikel
|
| 22 |
Taking the next step: a systematic review and meta-analysis of physical activity and behavior change interventions in recent post-treatment breast cancer survivors
|
Bluethmann, Shirley M.
|
|
2015
|
149 |
2 |
p. 331-342
|
artikel
|
| 23 |
The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family Registry
|
Cloud, Ann J.
|
|
2015
|
149 |
2 |
p. 537-546
|
artikel
|
| 24 |
The prognostic relevance of the mitotic activity index in axillary lymph node-negative breast cancer
|
Jobsen, Jan J.
|
|
2014
|
149 |
2 |
p. 343-351
|
artikel
|
| 25 |
Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
|
Groot, S. de
|
|
2015
|
149 |
2 |
p. 461-466
|
artikel
|
| 26 |
Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer
|
Yu, Anthony F.
|
|
2015
|
149 |
2 |
p. 489-495
|
artikel
|
Tijdschrift beschrijving